T. Rowe Price Associates
ARVN icon

T. Rowe Price Associates’s Arvinas ARVN Stock Holding History

T. Rowe Price Associates’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05M Buy
728,147
+301,054
+70% +$2.81M ﹤0.01% 1478
2026
Q1 		$4.53M Buy
427,093
+345,528
+424% +$4.28M ﹤0.01% 1460
2025
Q4 		$968K Sell
81,565
-5,751
-7% -$62.8K ﹤0.01% 2095
2025
Q3 		$744K Sell
87,316
-1,246,656
-93% -$9.46M ﹤0.01% 2193
2025
Q2 		$9.82M Sell
1,333,972
-2,491,092
-65% -$18.3M ﹤0.01% 1117
2025
Q1 		$26.9M Sell
3,825,064
-277,947
-7% -$4.36M ﹤0.01% 879
2024
Q4 		$78.7M Buy
4,103,011
+249,295
+6% +$6.06M 0.01% 627
2024
Q3 		$94.9M Sell
3,853,716
-135,153
-3% -$3.53M 0.01% 581
2024
Q2 		$106M Sell
3,988,869
-379,549
-9% -$12.1M 0.01% 535
2024
Q1 		$180M Buy
4,368,418
+536,295
+14% +$23.4M 0.02% 440
2023
Q4 		$158M Buy
3,832,123
+1,143,452
+43% +$26.7M 0.02% 457
2023
Q3 		$52.8M Sell
2,688,671
-5,365
-0.2% -$132K 0.01% 669
2023
Q2 		$66.9M Buy
2,694,036
+180,318
+7% +$4.64M 0.01% 624
2023
Q1 		$68.7M Buy
2,513,718
+145,588
+6% +$4.6M 0.01% 599
2022
Q4 		$81M Buy
2,368,130
+188,362
+9% +$7.92M 0.01% 535
2022
Q3 		$97M Sell
2,179,768
-1,087,802
-33% -$52.8M 0.02% 496
2022
Q2 		$138M Buy
3,267,570
+160,860
+5% +$8.07M 0.02% 573
2022
Q1 		$209M Buy
3,106,710
+196,104
+7% +$13.4M 0.02% 519
2021
Q4 		$239M Buy
2,910,606
+353,452
+14% +$28.8M 0.02% 514
2021
Q3 		$210M Buy
2,557,154
+77,385
+3% +$6.84M 0.02% 536
2021
Q2 		$191M Buy
2,479,769
+93,314
+4% +$6.48M 0.02% 577
2021
Q1 		$158M Buy
2,386,455
+141,006
+6% +$10.8M 0.02% 629
2020
Q4 		$191M Buy
2,245,449
+1,405,654
+167% +$48.5M 0.02% 541
2020
Q3 		$19.8M Sell
839,795
-19,230
-2% -$557K ﹤0.01% 1155
2020
Q2 		$28.8M Buy
859,025
+716,226
+502% +$30.4M ﹤0.01% 1030
2020
Q1 		$5.75M Buy
142,799
+117,548
+466% +$5.5M ﹤0.01% 1320
2019
Q4 		$1.04M Sell
25,251
-56,630
-69% -$1.66M ﹤0.01% 1868
2019
Q3 		$1.76M Buy
81,881
+56,560
+223% +$1.39M ﹤0.01% 1610
2019
Q2 		$557K Buy
+25,321
New +$532K ﹤0.01% 2069

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates's ARVN Position: Q2 2026 in Review

T. Rowe Price Associates increased its Arvinas (ARVN) stake by 70% in Q2 2026, buying an estimated $2.81M and bringing the position to 728,147 shares worth $6.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

T. Rowe Price Associates first reported a position in ARVN in Q2 2019 and has held it in 29 quarters since. The position peaked at $239M in Q4 2021. 201 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • T. Rowe Price Associates held 728,147 shares of Arvinas worth $6.05M as of Q2 2026.
  • T. Rowe Price Associates bought 301,054 Arvinas shares in Q2 2026, an estimated $2.81M.
  • Arvinas made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1478 holding.
  • T. Rowe Price Associates first reported a position in Arvinas in Q2 2019 and has held it in 29 quarters since.
  • T. Rowe Price Associates's Arvinas position peaked at $239M in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.